论文部分内容阅读
目的 观察降纤酶治疗急性脑梗死的疗效。 方法 将 57例急性脑梗死病人随机分为治疗组和对照组。治疗组 37例 (男性 2 8例 ,女性 9例 ,年龄 60 .59± 9.4 6岁 ) ,首次用降纤酶 1 0 u加入 0 .9%氯化钠 2 50 ml静脉滴注 ,以后 5u静脉滴注 ,即第 1、 3、 7、 1 1天给药 ,共 4次 ,总剂量 2 5u。对照组 2 0例(男性 1 2例 ,女性 8例 ,年龄 59.55± 1 2 .1 1岁 ) ,用脉通 50 0 ml,每天静脉滴注 1次 ,连用 2周。 结果 治疗组有效率为 91 % ,对照组有效率为 70 % (P <0 .0 5)。 结论 降纤酶是治疗急性脑梗死安全、有效的药物
Objective To observe the curative effect of defibrase on acute cerebral infarction. Methods 57 cases of acute cerebral infarction were randomly divided into treatment group and control group. The treatment group, 37 cases (28 males and 9 females, aged 60.59 ± 9.4 6 years), the first combination of defibrase 10 u 0.9% sodium chloride 2 50 ml intravenous infusion after 5u vein Dosing, that is, 1, 3, 7, 1 1 days of administration, a total of 4 times, a total dose of 25u. Control group of 20 patients (12 males and 8 females, age 59.55 ± 12.1.1 years), with pulse-pass 50 0 ml intravenous infusion once daily for 2 weeks. Results The effective rate was 91% in the treatment group and 70% in the control group (P <0.05). Conclusion Defibrase is a safe and effective drug for the treatment of acute cerebral infarction